User profiles for P. Bager

Peter Bager

- Verified email at ssi.dk - Cited by 3726

Palle Bager

- Verified email at rm.dk - Cited by 3336

Prevalence of anemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta-analysis

…, S Schneeweiss, S Ardizzone, P Bager… - Inflammatory Bowel …, 2014 - academic.oup.com
… Patients with ulcerative colitis tended to have anemia less likely than patients with Crohn's
disease (P = … All tests were 2-tailed and a P value of less than 0.05 was considered significant. …

Helminth therapy (worms) for induction of remission in inflammatory bowel disease

SK Garg, AM Croft, P Bager - Cochrane Database of …, 2014 - cochranelibrary.com
Bager 2011 reported that a single oral dose of T. suis eggs caused a three‐ to 19‐fold
increase in episodes of flatulence, diarrhoea and abdominal pain compared to placebo patients. …

ECCO guidelines on therapeutics in Crohn's disease: medical treatment

…, A Armuzzi, O Bachmann, P Bager… - Journal of Crohn's …, 2020 - academic.oup.com
2. Methods Based on the GRADE workflow, the Guidelines Committee of ECCO [GuiCom]
selected a panel of 48 experts supported by a team of methodologists and librarians. …

Caesarean delivery and risk of atopy and allergic disesase: meta‐analyses

P Bager, J Wohlfahrt… - Clinical & Experimental …, 2008 - Wiley Online Library
Background Studies of delivery by caesarean section (c‐section) and the offspring's risk of
allergic diseases are of current interest due to concerns about the increased use of c‐section …

ECCO guidelines on therapeutics in Crohn's disease: surgical treatment

…, A Armuzzi, O Bachmann, P Bager… - Journal of Crohn's …, 2020 - academic.oup.com
This article is the second in a series of two publications relating to the European Crohn’s
and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn’s …

Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study

P Bager, J Wohlfahrt, S Bhatt, M Stegger… - The Lancet infectious …, 2022 - thelancet.com
Background Estimates of the severity of the SARS-CoV-2 omicron variant (B.1.1.529) are
crucial to assess the public health impact associated with its rapid global dissemination. We …

[HTML][HTML] Risk of reinfection, vaccine protection, and severity of infection with the BA. 5 omicron subvariant: a nation-wide population-based study in Denmark

CH Hansen, NU Friis, P Bager, M Stegger… - The Lancet Infectious …, 2023 - thelancet.com
… repeated using a matched case-control design in which cases and controls were pair-matched
on test date, sex, and age (for further details about the methods used, see the appendix p

Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial

P Bager, J Arnved, S Rønborg, J Wohlfahrt… - Journal of allergy and …, 2010 - Elsevier
… on prick testing with 9 allergens excluding grass (P = .85) when comparing skin prick testing
… after the last treatment (P = .85) nor in titers of grass-IgE during the grass season (P = .40) …

[HTML][HTML] Molecular epidemiology of the SARS-CoV-2 variant Omicron BA. 2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022

J Fonager, M Bennedbæk, P Bager… - …, 2022 - eurosurveillance.org
Following emergence of the SARS-CoV-2 variant Omicron in November 2021, the dominant
BA.1 sub-lineage was replaced by the BA.2 sub-lineage in Denmark. We analysed the first …

Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B. 1.1. 7 in Denmark: an observational cohort study

P Bager, J Wohlfahrt, J Fonager… - The Lancet Infectious …, 2021 - thelancet.com
… (p<0·0001), a slightly lower proportion among women than among men (p<0·0001), different
proportions between regions (p… with comorbidities than in those without (p<0·0001). Among …